EA201171200A1 - Полиморфы элтромбопага и солей элтромбопага, а также способы их получения - Google Patents
Полиморфы элтромбопага и солей элтромбопага, а также способы их полученияInfo
- Publication number
- EA201171200A1 EA201171200A1 EA201171200A EA201171200A EA201171200A1 EA 201171200 A1 EA201171200 A1 EA 201171200A1 EA 201171200 A EA201171200 A EA 201171200A EA 201171200 A EA201171200 A EA 201171200A EA 201171200 A1 EA201171200 A1 EA 201171200A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- eltrombopag
- polymorphos
- salts
- obtaining
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
- C07D231/46—Oxygen atom in position 3 or 5 and nitrogen atom in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Abstract
Получены и охарактеризованы новые полиморфные формы Элтромбопага и этаноламиновой соли Элтромбопага. Указанные полиморфные формы и фармацевтические композиции, включающие их, полезны, например, при терапии патологических состояний, приводящих к тромбоцитопении.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16563809P | 2009-04-01 | 2009-04-01 | |
US16729709P | 2009-04-07 | 2009-04-07 | |
US17189409P | 2009-04-23 | 2009-04-23 | |
US17701909P | 2009-05-11 | 2009-05-11 | |
US18096109P | 2009-05-26 | 2009-05-26 | |
US22368509P | 2009-07-07 | 2009-07-07 | |
US26636409P | 2009-12-03 | 2009-12-03 | |
PCT/US2010/029532 WO2010114943A1 (en) | 2009-04-01 | 2010-04-01 | Polymorphs of eltrombopag and eltrombopag salts and processes for preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201171200A1 true EA201171200A1 (ru) | 2012-04-30 |
EA022756B1 EA022756B1 (ru) | 2016-02-29 |
Family
ID=42126157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201171200A EA022756B1 (ru) | 2009-04-01 | 2010-04-01 | Кристаллические формы элтромбопага и их применение |
Country Status (9)
Country | Link |
---|---|
US (4) | US7956048B2 (ru) |
EP (1) | EP2414336A1 (ru) |
JP (2) | JP2012522792A (ru) |
KR (3) | KR101377778B1 (ru) |
CN (1) | CN102448942A (ru) |
CA (1) | CA2757458A1 (ru) |
EA (1) | EA022756B1 (ru) |
TW (1) | TWI379681B (ru) |
WO (1) | WO2010114943A1 (ru) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102448942A (zh) | 2009-04-01 | 2012-05-09 | 普利瓦赫尔瓦茨卡有限公司 | 艾曲波帕和艾曲波帕盐的多晶型物及其制备方法 |
WO2013072921A2 (en) * | 2011-09-13 | 2013-05-23 | Glenmark Generics Limited | Process for preparation of substituted 3'-hydrazino-biphenyl-3-carboxylic acid compounds |
WO2013049605A1 (en) | 2011-09-28 | 2013-04-04 | Assia Chemical Industries Ltd. | Processes for the preparation of an intermediate in the synthesis of eltrombopag |
EP2799425A1 (en) | 2013-04-29 | 2014-11-05 | Esteve Química, S.A. | Preparation process of an agonist of the thrombopoietin receptor |
WO2015111085A2 (en) | 2014-01-27 | 2015-07-30 | Cadila Healthcare Limited | Processes for the preparation of eltrombopag and pharmaceutically acceptable salts, solvates and intermediates thereof |
CN103819406B (zh) * | 2014-03-17 | 2015-04-08 | 苏州明锐医药科技有限公司 | 艾曲波帕的制备方法 |
WO2016035018A1 (en) * | 2014-09-05 | 2016-03-10 | Hetero Research Foundation | Crystalline form of eltrombopag free acid |
CN105412930A (zh) * | 2015-08-07 | 2016-03-23 | 军事医学科学院华南干细胞与再生医学研究中心 | 血小板生成素受体激动剂在促进造血干细胞归巢中的用途 |
CN105801444B (zh) * | 2016-04-15 | 2017-08-04 | 启东东岳药业有限公司 | 3’‑氨基‑2’‑羟基联苯‑3‑羧酸的合成方法 |
CN107870217B (zh) * | 2016-09-26 | 2022-03-04 | 齐鲁制药有限公司 | 艾曲波帕中间体ⅰ有关物质的检测方法 |
AU2017341136B2 (en) | 2016-10-06 | 2021-07-08 | Kyowa Hakko Bio Co., Ltd. | Crystal of cytidine diphosphate choline and production method thereof |
CN108033914A (zh) * | 2016-12-27 | 2018-05-15 | 浙江万晟药业有限公司 | 一种艾曲泊帕的制备方法 |
CN106966984A (zh) * | 2017-04-01 | 2017-07-21 | 常州制药厂有限公司 | 艾曲波帕二乙醇胺盐的制备方法 |
EP3395331B1 (en) | 2017-04-26 | 2019-08-21 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Pharmaceutical tablet composition comprising eltrombopag olamine |
CN108191763A (zh) * | 2018-02-10 | 2018-06-22 | 扬子江药业集团四川海蓉药业有限公司 | 一种艾曲泊帕乙醇胺的合成方法 |
EP3409272B1 (en) | 2018-03-07 | 2020-06-24 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Pharmaceutical composition comprising eltrombopag olamine, reducing sugar, and polymeric binder |
EP3802651A4 (en) * | 2018-06-01 | 2022-05-04 | Aurobindo Pharma Limited | IMPROVED PROCESS FOR THE MANUFACTURE OF ELTROMBOPAG OLAMINE AND ITS INTERMEDIATE PRODUCTS |
EP3604284B1 (en) | 2018-08-02 | 2020-11-11 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Crystalline eltrombopag monoethanolamine salt form d |
ES2815924T3 (es) | 2018-08-02 | 2021-03-31 | Fis Fabbrica Italiana Sintetici Spa | Forma D1 cristalina altamente estable de la sal de monoetanolamina de eltrombopag |
CN114341113A (zh) * | 2019-10-21 | 2022-04-12 | 广东东阳光药业有限公司 | 乙酰化艾曲波帕的新晶型及其制备方法 |
CN114341112A (zh) * | 2019-10-21 | 2022-04-12 | 广东东阳光药业有限公司 | 乙酰化艾曲波帕的新晶型及其制备方法 |
WO2022056346A1 (en) * | 2020-09-14 | 2022-03-17 | Actavis Laboratories Fl, Inc. | Eltrombopag choline dosage forms |
WO2022071896A1 (en) * | 2020-09-30 | 2022-04-07 | Deva Holding | Eltrombopag novel salts |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CY2010012I2 (el) | 2000-05-25 | 2020-05-29 | Novartis Ag | Μιμητικα θρομβοποιητινης |
US6818398B2 (en) * | 2000-12-29 | 2004-11-16 | The University Of Chicago | Column device for isolation and labeling of nucleic acids |
AR040083A1 (es) * | 2002-05-22 | 2005-03-16 | Smithkline Beecham Corp | Compuesto bis-(monoetanolamina) del acido 3'-[(2z)-[1-(3,4-dimetilfenil) -1,5-dihidro-3-metil-5-oxo-4h-pirazol-4-iliden] hidrazino] -2'-hidroxi-[1,1'-bifenil]-3-carboxilico, procedimiento para prepararlo, composicion farmaceutica que lo comprende, procedimiento para preparar dicha composicion farmac |
ECSP077628A (es) * | 2007-05-03 | 2008-12-30 | Smithkline Beechman Corp | Nueva composición farmacéutica |
CN102448942A (zh) * | 2009-04-01 | 2012-05-09 | 普利瓦赫尔瓦茨卡有限公司 | 艾曲波帕和艾曲波帕盐的多晶型物及其制备方法 |
-
2010
- 2010-04-01 CN CN2010800249175A patent/CN102448942A/zh active Pending
- 2010-04-01 KR KR1020117023067A patent/KR101377778B1/ko active IP Right Grant
- 2010-04-01 JP JP2012503683A patent/JP2012522792A/ja active Pending
- 2010-04-01 EP EP10712847A patent/EP2414336A1/en not_active Withdrawn
- 2010-04-01 KR KR1020137018548A patent/KR20130088197A/ko active Application Filing
- 2010-04-01 CA CA2757458A patent/CA2757458A1/en not_active Abandoned
- 2010-04-01 US US12/752,642 patent/US7956048B2/en active Active
- 2010-04-01 KR KR1020147030670A patent/KR20140138349A/ko not_active Application Discontinuation
- 2010-04-01 WO PCT/US2010/029532 patent/WO2010114943A1/en active Application Filing
- 2010-04-01 TW TW099110171A patent/TWI379681B/zh active
- 2010-04-01 EA EA201171200A patent/EA022756B1/ru not_active IP Right Cessation
-
2011
- 2011-04-19 US US13/089,482 patent/US8022093B2/en active Active
- 2011-08-04 US US13/198,214 patent/US8217021B2/en active Active
-
2012
- 2012-06-01 US US13/486,688 patent/US8372822B2/en active Active
-
2014
- 2014-11-04 JP JP2014224591A patent/JP2015044844A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
TW201039818A (en) | 2010-11-16 |
TWI379681B (en) | 2012-12-21 |
US20120238612A1 (en) | 2012-09-20 |
US20100256212A1 (en) | 2010-10-07 |
US8372822B2 (en) | 2013-02-12 |
US8217021B2 (en) | 2012-07-10 |
WO2010114943A1 (en) | 2010-10-07 |
EA022756B1 (ru) | 2016-02-29 |
US20110196008A1 (en) | 2011-08-11 |
US8022093B2 (en) | 2011-09-20 |
JP2015044844A (ja) | 2015-03-12 |
KR20130088197A (ko) | 2013-08-07 |
KR101377778B1 (ko) | 2014-03-27 |
CA2757458A1 (en) | 2010-10-07 |
US20120022124A1 (en) | 2012-01-26 |
KR20120000563A (ko) | 2012-01-02 |
JP2012522792A (ja) | 2012-09-27 |
EP2414336A1 (en) | 2012-02-08 |
CN102448942A (zh) | 2012-05-09 |
KR20140138349A (ko) | 2014-12-03 |
US7956048B2 (en) | 2011-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201171200A1 (ru) | Полиморфы элтромбопага и солей элтромбопага, а также способы их получения | |
EA201071264A1 (ru) | Аминодигидротиазиновые производные в качестве ингибиторов bace для лечения болезни альцгеймера | |
EA201390772A1 (ru) | Новые соли и полиморфные формы афатиниба | |
EA201391274A1 (ru) | Аминохинолины в качестве ингибиторов киназ | |
EA201170161A1 (ru) | 1,2,5-оксадиазолы в качестве ингибиторов индоламин-2,3-диоксигеназы | |
EA201490971A1 (ru) | Производные урацила в качестве ингибиторов axl и c-met киназы | |
EA201000642A1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
EA201590748A1 (ru) | Противовирусные соединения против rsv | |
EA201690930A1 (ru) | Композиции и способы модуляции фарнезоидных х-рецепторов | |
EA201270339A1 (ru) | Замещенные производные ксантина | |
EA201490540A1 (ru) | Соединения и композиции в качестве ингибиторов с-kit киназы | |
EA201490474A1 (ru) | Аминохиназолины в качестве ингибиторов киназ | |
EA201290980A1 (ru) | Производные 1-амино-2-циклопропилэтилбороновой кислоты | |
EA201790515A1 (ru) | Противовирусные соединения | |
EA201390766A1 (ru) | БЕНЗОКСАЗЕПИНЫ КАК ИНГИБИТОРЫ PI3K/mTOR И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ И ПОЛУЧЕНИЯ | |
EA201101650A1 (ru) | Новые производные пиримидина и их применение в лечении злокачественных новообразований и последующих заболеваний | |
EA201391019A1 (ru) | Соединения и способы для модуляции киназ, а также показания к их применению | |
EA201071329A1 (ru) | Диамидные производные адамантана и их применение | |
EA201390579A1 (ru) | Производные хиназолин-4(3h)-она, используемые как ингибиторы pi3-киназы | |
EA201270575A1 (ru) | Соединения | |
EA201290416A1 (ru) | Новые спиропиперидиновые соединения | |
EA201170356A1 (ru) | Полиморфные и аморфные формы лакозамида и аморфные композиции | |
EA201270535A1 (ru) | Пуриновые производные, применимые в качестве ингибиторов hsp90 | |
EA201391288A1 (ru) | Производные пиразолоспирокетонов для применения в качестве ингибиторов ацетил-коа-карбоксилаз | |
EA201101686A1 (ru) | Новые композиции для лечения шмт и связанных с ней расстройств |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |